
Resources
-
Host Cell Proteins: Sample Preparation, Methods, Instruments, Software, and Validation
Roundtable 5 Notes: Mass Spec 2019
-
Considerations for Placing Mass Spec in the High-throughput Lab
Roundtable 4 Notes: Mass Spec 2019
-
When Is It Time to Change the HPLC Stationary Phase in an HPLC/MS Lab?
Roundtable 3 Notes: Mass Spec 2019
-
From Sample Prep to Data Analysis
Roundtable 2 Notes: Mass Spec 2019
-
Alternative Separation Strategies – What Works, and What Is a Work-in-progress
Roundtable 1 Notes: Mass Spec 2019
-
New QC Identity Testing For Acellular Pertussis Combination Vaccines Using LC-MS
Speaker Presentation Zhang Hong, Sanofi Pasteur, 2019
-
A Regulatory Perspective on the Use of Mass Spectrometry for QC Testing of Therapeutic Proteins
Speaker Presentation Namuswe Frances, CDER, FDA, 2019
-
Resolving Complex Impurity Isomers in Synthetic Oligonucleotides by High Resolution Mass Spectrometry
Speaker Presentation Yang Kui, FDA, 2019
-
Automated Sequence Variant Analysis Supporting High Tier Media Selection
Speaker Presentation Zhai Bo, Janssen, 2019
-
A Single Approach (LITPOMS) Reveals Composite Conformational Changes, Order of Binding, and Affinities for Calcium Binding to Calmodulin
Speaker Presentation Liu Roger, Washington University, St. Louis, 2019
-
Applications of Mass Spectral Libraries to Therapeutic Protein Analysis: From Simultaneous Assessment of Post-Translational Modification Sites to Multi-Attribute Quality Control
Speaker Presentation Dong Qian, NIST, 2019
-
Ionic Charge Manipulation Using Solution- and Gas-phase Chemistry to Facilitate Analysis of Highly Heterogeneous Proteins by ESI-MS
Speaker Presentation Yang Yang, University of Massachusetts, Amherst, 2019
-
Analytical Strategies for Defining Biotech Product Quality
Speaker Presentation Harris Reed, Genentech, 2019
-
Mass Spectrometry in Process Development of Therapeutic Proteins
Speaker Presentation Bondarenko Pavel, Amgen, 2019
-
Developing an Industrial Platform for Advanced Multi-Faceted Characterization of Emerging Complex Biologics
Speaker Presentation Bailey Aaron, BGI Americas, 2019
-
What Attributes Have Not Been Explored Using CE Methodologies?
Roundtable 11 Notes: CE Pharm 2019
-
Troubleshooting Complex Separations
Roundtable 10 Notes: CE Pharm 2019
-
The Good, The Bad and The Ugly for Charge Heterogeneity: Which Electrophoretic Method to Pick and When?
Roundtable 9 Notes: CE Pharm 2019
-
Specification Setting for CE Methods
Roundtable 8 Notes: CE Pharm 2019
-
Peak Characterization of CE-based Size and Charge Heterogeneity Methods?
Roundtable 7 Notes: CE Pharm 2019